Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
In this study we intend to evaluate the outcome of intravitreal avastin on improving the
visual acuity and macular edema and late complications of BRVO like NVD and NVE